GT Diagnostics Ltd is part of the Genting TauRx Diagnostic Centre Sdn Bhd. It has been founded as a joint venture between Genting Bhd and TauRx Therapeutics Ltd. The aim of GT Diagnostics is to disrupt the current diagnostic market, addressing the massive mismatch between what is needed/demanded and what systems are currently available at an affordable price.
GT Diagnostics is developing inexpensive and accurate assessment tools for dementia diagnosis. Our e-platforms have the potential to become hubs for e-commerce, not only for linked services (financial and professional services, personal advice and support, residential and non-residential care, specialised products) but ultimately providing new channels for drug sales, distribution and monitoring.
Genting Berhad are embracing innovation and the adoption of new technology while TauRx Therapeutics are commited to the development of a treatment for dementia. As a result of their partnership, they have founded GT Diagnostics to provide intelligent tools to assist with early dementia detection.